Watchdog Group Identifies Critical Gaps in Oversight of Toxic Substances in Children’s Products

The U.S. Government Accountability Office (GAO) has identified significant opportunities for the Consumer Product Safety Commission (CPSC) to enhance its oversight of toxic substances present in children’s products. The report, publicly released on February 23, 2026, highlights existing challenges in enforcing compliance with safety standards, particularly given the vast number of product shipments entering the United States annually. While the CPSC is slated to implement new electronic filing requirements for importers, the GAO points out that the agency has not yet developed a comprehensive plan to ensure the accuracy and timeliness of this crucial data. Furthermore, the report suggests the CPSC could strengthen its assessment of potential risks posed by the third-party laboratories responsible for testing these products.

Currently, the CPSC employs risk-based strategies to identify children’s products potentially containing hazardous substances at U.S. ports. These methods involve utilizing U.S. Customs and Border Protection systems that analyze national shipment and law enforcement data to target high-risk items. The examination process includes screening products for lead and other toxic materials using handheld devices and verifying importer documentation to confirm that products have been tested by accredited third-party laboratories and meet CPSC safety standards.

A pivotal upcoming change, scheduled to take effect in July 2026, will mandate importers to electronically submit key data, including product identification and testing location, as products arrive at U.S. ports. CPSC officials anticipate this electronic filing, or “e-filing,” system will help alleviate existing obstacles, such as delays stemming from incomplete lab testing documentation. However, the GAO report underscores that the CPSC has not yet established a clear oversight plan to guarantee that importers will adhere to these e-filing requirements with accuracy and promptness. The development of such a plan is deemed essential for the CPSC to effectively leverage the e-filing system to improve targeting capabilities and streamline examinations, ultimately bolstering the protection of children from harmful substances.

The CPSC maintains review processes to confirm that third-party laboratories tasked with testing children’s products meet accreditation and other stipulated requirements. For laboratories that are owned or controlled by manufacturers or government entities, specific protocols are in place requiring them to provide information detailing safeguards against undue influence. Despite these measures, the GAO found that the CPSC has not proactively conducted a comprehensive analysis of data across all types of testing labs to identify potential risks, such as inaccurate testing results or misreported data. While the CPSC has recently initiated an analysis of violation data specifically for manufacturer-owned labs to better evaluate their internal controls, this practice does not extend to independent or government-affiliated labs. By more effectively utilizing its existing violation data for all categories of labs, the CPSC would be better positioned to detect and address potential issues, thereby preventing products that do not meet safety standards from reaching the market.

In addition to these concerns, the GAO report notes that while the CPSC has revised some testing requirements for children’s products, its standards for lead and phthalates – chemicals used to increase the flexibility of plastics – have not been updated. The Consumer Product Safety Improvement Act of 2008 mandates that the CPSC review its lead requirements at least every five years, a review that has not been conducted. Furthermore, the CPSC lacks documented procedures to guide its staff in monitoring changes related to phthalates and other toxic substances that may be present in children’s products. By undertaking a review of its lead requirements and formalizing a process for staying abreast of developments concerning toxic substances, the CPSC could identify opportunities to strengthen its regulations and enhance the safety of children’s products.

The GAO’s recommendations to the CPSC include establishing a plan to oversee compliance with the new e-filing requirements, developing a process for using violation data to assess risks associated with independent and government labs, completing a review of lead requirements for children’s products as mandated by law and documenting a five-year review cycle, and formalizing a process for staying updated on changes related to phthalates and other toxic substances. The CPSC has indicated its agreement with these recommendations and plans to implement them.

Article by Mel Anara, based upon information from the U.S. Government Accountability Office

---